arginyl-glycyl-aspartyl-serine has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Cheng, Q; Fu, B; Li, W; Wang, J; Xu, Q; Ye, Y; Yu, L | 1 |
1 other study(ies) available for arginyl-glycyl-aspartyl-serine and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Integrin alphavbeta3-RGDS interaction mediates fibrin-induced morphological changes of glomerular endothelial cells.
Topics: Antibodies, Monoclonal; Cell Communication; Cell Division; Cells, Cultured; Cycloheximide; Dactinomycin; Endothelium; Fibrin; Fibrinogen; Gelatin; Gels; Glomerulosclerosis, Focal Segmental; Humans; Kidney Glomerulus; Oligopeptides; Platelet Aggregation Inhibitors; Protein Synthesis Inhibitors; Receptors, Vitronectin | 1999 |